Stay updated on Volitinib for Primary CNS Tumors Clinical Trial
Sign up to get notified when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.

Latest updates to the Volitinib for Primary CNS Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe revision history now shows a new entry for v3.4.2, replacing v3.4.1. This is a minor metadata update and does not alter study information.SummaryDifference0.0%

- Check19 days agoChange DetectedA minor revision from v3.4.0 to v3.4.1 was issued; no visible changes to core content or study details are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check26 days agoChange DetectedGlossary toggle is now visible on the page. Footer metadata has been updated to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the previous labels.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3, reflecting a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a Locations section listing study sites (California, Colorado, District of Columbia, Illinois, New York, Ohio, Pennsylvania, Tennessee, Texas, Ontario). Updated revision tag from v3.3.2 to v3.3.3.SummaryDifference1.0%

- Check91 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no changes to core study content or metadata were made. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Volitinib for Primary CNS Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.